Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
MailMyPrescriptions.com
AddedFeb 16, 2024
UpdatedJun 18, 2026
MailMyPrescriptions.com

MailMyPrescriptions.com

Seed

MailMyPrescriptions.com: Your affordable mail-order pharmacy. We handle prescriptions, provide care, and deliver within 5 days.

HQ
Boca Raton, FL, US
Founded
2015
Overview
Compare
Fundraising
Employees

MailMyPrescriptions.com is a mail-order pharmacy dedicated to offering low-cost generic drugs with guaranteed low cash pay prices on over 1,400 FDA-approved medications. The company manages the entire process, from obtaining prescriptions to providing clinical care and shipping directly to customers' doors, typically within five days. This service eliminates the need for price shopping, discount coupons, or pharmacy visits, helping customers save up to 90% over retail prices.

MailMyPrescriptions.com has significantly impacted the pharmaceutical market by making essential medications more accessible and affordable. Its streamlined process and commitment to customer care have garnered positive feedback and trust from users. The company's innovative approach to pharmacy services has set a new standard for convenience and cost savings in the industry.

MailMyPrescriptions.com - Quick Facts

When was MailMyPrescriptions.com founded?

MailMyPrescriptions.com was founded in 2015.

Where is MailMyPrescriptions.com's headquarters located?

MailMyPrescriptions.com's headquarters is located in Boca Raton, FL, US.

When was MailMyPrescriptions.com's last funding round?

MailMyPrescriptions.com's most recent funding round was for $1.6M (USD) in November 2015.

How much has MailMyPrescriptions.com raised to-date?

As of Nov 15, 2015, MailMyPrescriptions.com has raised a total of $1.6M (USD).

How many employees does MailMyPrescriptions.com have?

MailMyPrescriptions.com has 75 employees as of Feb 4, 2024.

MailMyPrescriptions.com - Classification

Industry
  • Retail
Ownership
  • Private
Technology
  • Telemedicine
Geographic Exposure
  • United States
Revenue
  • Transactional
Customer
  • Consumers
Main Product
  • Generic Drugs
  • Pharmacy
Tags
  • eCommerce
  • Healthtech
NAICS
  • 456000Health and Personal Care Retailers
  • 450000Retail Trade
  • 456100Health and Personal Care Retailers
  • 456110Pharmacies and Drug Retailers
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
Show 11 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 5900Miscellaneous Retail
  • 2830Drugs
  • 5910Drug Stores And Proprietary Stores
  • 2834Pharmaceutical Preparations